Li JM - Search Results

1

[Prognostic significance of 18F-FDG PET/CT in aggressive non- Hodgkin's lymphoma: a 10-year retrospective study on 105 cases].

Guo N, Li XY, Zhu HM, Li JM. Guo N, et al. Among authors: li jm, li xy. Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):722-4. doi: 10.3760/cma.j.issn.0253-2727.2013.08.018. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23978029 Chinese. No abstract available.

2

[Epidemiology and drug resistance of the pathogenic microbes in the complicated infection of hematological malignancies].

Shen Y, Shen J, Chen Y, Zeng XY, Li JM, Ni YX, Shen ZX. Shen Y, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):328-32. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15308008 Chinese.

3

[Efficacy and safety of imatinib in treatment of 151 chronic myeloid leukemia patients].

Zhou L, Wang AH, Wang L, You JH, Li JM, Shen ZX. Zhou L, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2008 Jan;29(1):13-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18512309 Chinese.

4

[Prognostic factors analysis for R-CHOP regimen therapy in diffuse large B cell lymphoma].

Shen Y, Yao Y, Li JM, Chen QS, You JH, Zhao HJ, Chen S, Shen ZX. Shen Y, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):252-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843980 Chinese.

5

[Comparisons of conventional and normalized calculation of quantitative real-time RT-PCR detecting PML-RAR alpha fusion gene in patients with acute promyelocytic leukemia].

Hu J, Gao XD, Liu YF, Zhu YM, Li JM, Shen ZX. Hu J, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2008 May;29(5):304-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18844066 Chinese.

6

[Nilotinib treatment for imatinib resistant or intolerant chronic myelogenous leukemia.].

Wang AH, Zhou L, You JH, Wang L, Li JM, Hu J, Shen ZX. Wang AH, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2010 Jan;31(1):11-5. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20302768 Chinese.

7

[Research progress on second-hit in malignant lymphomagenesis-- review].

Li XY, Li JM. Li XY, et al. Among authors: li jm. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1627-31. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21176385 Review. Chinese.

8

[Treatment outcome analysis of CTOP or CHOP regimen in newly diagnosed aggressive non-Hodgkin's lymphoma patients-results of a prospective, open, randomized, multicenter clinical trial].

Wang YY, Zhang JL, Wang C, Wang X, Wu DP, Liang H, Zhu J, Li JM, Shen ZX. Wang YY, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2010 Oct;31(10):649-53. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 21223712 Clinical Trial. Chinese.

9

[Analysis of outocome of pirarubicin-based combination chemotherapy regimen in the treatment of newly diagnosed acute myeloid leukemia-a prospective, open, randomized and multicenter clinical trial].

Wang YY, Sheng XM, Zhang RY, Guo XN, Sun H, Wang X, Zhang JL, Li JM, Shen ZX. Wang YY, et al. Among authors: li jm. Zhonghua Xue Ye Xue Za Zhi. 2010 Nov;31(11):748-51. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 21223729 Chinese.

10

[Research progress of tumor microenvironment and non-Hodgkin's lymphomas].

Chen JX, Li JM. Chen JX, et al. Among authors: li jm. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):843-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21729585 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,748 results

Search Page

Filters